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Abstract

There are over 90 safe injection facilities (SIFs) in at least 11 countries around the world, except
in the United States. SIFs are spaces where people who inject drugs (PWID) can bring their preobtained drugs in a hygienic space and use them under supervision. The goal of these sites is to
reduce the harmful effects of injection drug use and refer PWID to other medical, social, and
treatment services. The Safer Inside Coalition, a community-driven health initiative, in the
Tenderloin district of San Francisco recommended opening a SIF in the Tenderloin to improve
the health of the community and individual drug users. The purpose of this project was to
develop an operational plan for a SIF. Based on a literature review and coalition meetings, two
operational plan models were developed – a centralized model and an integrated model. These
were compiled in a report for community organizations to review to assess feasibility of
implementing these services in the Tenderloin district. Further development needs to be done to
work out more specific details based on the model that is chosen and the needs of the
community.
Keywords: harm reduction, injection drug use, Tenderloin, San Francisco, drug treatment,
recovery
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Executive Summary

There are approximately 7,000 people who inject drugs in the Tenderloin district of San
Francisco. Many of these people are homeless and are injecting in public places and disposing
their syringes in the street, endangering their lives and the community. The Safer Inside coalition
is a community-driven health initiative that includes members of different organizations in the
Tenderloin working towards improving the health and safety of the Tenderloin and drug users
within the community. One of the priority recommendations for the group was to establish
operational plans for a safe injection facility in the Tenderloin.
Safe injection facilities are legal spaces where people can bring pre-obtained drugs and
use them under supervision in a hygienic environment. The goals of these facilities are to reduce
morbidity and mortality, public drug use, discarded needles and HIV and Hepatitis C risks. They
also serve as a linkage to drug treatment, health services, and social services. While there are no
current safe injection services in the United States, this approach is being used in at least 10 other
countries with over 90 sites worldwide. The two main models are centralized and de-centralized.
A de-centralized model or integrated model is where safe injection services are added to an
existing harm reduction program. A centralized or specialized site is one that is independent from
other programs and whose purpose is just to provide supervised injection and education with
referrals to other services.
Based on the research from other models around the world and conversations with
members of the Safer Inside coalition, two operational plans were developed – a specialized
model and integrated model. These were presented in a report for executive directors of
community organizations to view and discuss to determine which model would be the best fit for
the community.
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The report contains:
•

Background information about Safer Inside

•

Major assumptions that the plans were based on, including information from a
law currently being debated in the California legislature on this topic

•

An overview of service for both models

•

A side-by-side outline of components for the two models

•

Justifications for the different program features, explaining what the
recommendations were based on

•

Evaluation measures from an operational standpoint

•

Other considerations that need to be discussed

•

A preliminary budget for a specialized site was also added but the costs for some
components still need to be added by organizations with more accurate numbers.
The budget serves as a template for the coalition members and executive directors
to start thinking about the different components that will be needed and can be
adjusted based on the model that is chosen.

This document is a preliminary document that can still be added to based on input from
other stakeholders and other experts. These operational plans are designed to be used as a twoyear demonstration project and the impacts of the site are to be evaluated. There are advantages
to each model and ultimately the goal is to clean up the streets of the Tenderloin and promote the
health of people who inject drugs.
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There are an estimated 22,500 people who inject drugs (PWID) in San Francisco (Chen,
McFarland, & Raymond, 2016). The majority of them are homeless (68.6%) and almost half of
them use heroin (San Francisco Department of Public Health [SFDPH], 2017). Furthermore, in
San Francisco, PWID account for 21% of people with HIV and approximately 70% of active
Hepatitis C infections (SFDPH, 2017). Death due to heroin, fentanyl, and methamphetamine in
San Francisco has also been increasing in recent years. The city’s Tenderloin district has the
largest percentage of unintentional opioid or stimulant deaths (33%) and the largest percentage of
PWID (31%) (SFDPH, 2017).
San Francisco has used a variety of harm reduction methods to treat the substance abuse
disorders in the city such as providing syringe exchange programs and making it easier to obtain
sterile syringes from pharmacies. The city also increased the availability of publicly-funded
substance use treatment and medication-assisted treatment for opioid addiction. San Francisco
was the first city in the United States to use public funds to increase the availability of naloxone
to reduce the number of opioid overdoses (SFDPH, 2017).
Despite these efforts, there is still a problem with public injecting, especially in the
Tenderloin. Safe injection facilities (SIF) provide a safe space where PWID can inject drugs
using clean supplies under supervision and which connects them to other social and health
services. Safer Inside: A community-driven initiative for a healthier Tenderloin is a coalition
comprised of members of different organizations in the Tenderloin working towards improving
the health and safety of the Tenderloin and drug users within the community. One of the priority
recommendations of the coalition was to develop operational plans for a SIF in the Tenderloin.
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Review of Literature

Harm Reduction Philosophy
Harm reduction is a social policy that started gaining attention in the 1980s relating to
drug use. It was introduced as an alternative to abstinence-only treatment for substance abuse.
The priority in harm reduction is to decrease the harmful consequences of drug use, whereas, the
priority of abstentionism is to reduce the prevalence of drug use (Pates & Riley, 2012). The main
principles of harm reduction are: pragmatism, humanistic values, focus on harms, and hierarchy
of goals. Pragmatism involves accepting that some use of drugs is normal or inevitable in
society. Humanistic values focuses on respecting the dignity and rights of drug users without
judgment on their use. Focus on harms is recognizing that the potential harm from use is more
important than the extent of drug use. Finally, hierarchy of goals is where harm reduction
programs focus on the most urgent needs (Pates & Riley, 2012).
There are many different types of programs that fit into the category of harm reduction.
These include needle/syringe exchange programs, opiate substitution therapies, and supervised
injection facilities. There is strong evidence that opiate substitution therapies are effective in
decreasing adverse effects of injecting drugs (Korsmeyer & Kranzler, 2009; MacArthur et al.,
2014). Another popular harm reduction method is syringe or needle exchange programs. These
have been shown to reduce the incidence of HIV while also helping drug users connect with
other services (Korsmeyer & Kranzler, 2009). Safe injection facilities are another form of harm
reduction because they can be used to treat overdoses early and save lives.
History of Safe Injection Services
Safe injection facilities (SIF) or drug-consumption rooms (DCR) are defined as legally
sanctioned facilities that allow for the hygienic consumption of pre-obtained drugs under
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supervision (Kimber, Dolan, Van Beek, Hedrich, & Zurhold, 2003). The primary goals of these
services are to reduce public drug use, morbidity and mortality, inappropriately discarded
needles, HIV and Hepatitis C (HCV) risks, and to serve as a gateway to drug treatment, health
services, and social services (Kimber et al., 2003). These spaces evolved from health and public
issues related to large urban drug scenes that were not being addressed by existing programs. The
establishment of a SIF was usually the result of a local effort to change policies to allow these
services to be introduced (European Monitoring Centre for Drugs and Drug Addiction
[EMCDDA, 2016)
The first DCR was opened in Berne, Switzerland in 1986. Since then SIFs and DCRs
have been established in Germany, Netherlands, Spain, Norway, Luxembourg, Denmark, Greece,
France, and Switzerland with a total of 90 DCRs in Europe. Other European nations that are
considering opening SIFs are Slovenia, Scotland, Ireland, and Belgium (European Monitoring
Centre for Drugs and Drug Addiction [EMCDDA], 2017). There is one medically supervised
injection site in Sydney, Australia and no official sites in Asia or South America (EMCDDA,
2017).
In 2003, Canada opened Insite in Vancouver, the first legally approved SIF in North
America. It was allowed to operate as a research pilot program as an exception under the
Canadian Controlled Drugs and Substances Act (Hedrich, 2004). In 2006, the Canadian federal
government threatened to revoke the exemption which led to supporters taking the case to the
Supreme Court. In September 2011, the Canadian Supreme Court made a unanimous ruling in
favor of Insite staying open (Hyshka, Bubela, & Wild, 2013). Dr. Peter Centre in Vancouver is a
clinic for people living with HIV/AIDs that also provides supervised injection services for
members. It was approved for the same exemption as Insite (Lupnick, 2016). As of June 2017,
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there were two more sites that opened in Surrey, B.C. These sites are the first that have been
approved for allowing substances taken orally and nasally, in addition to injecting (Bains, 2017).
Three sites in Montreal have also opened in June 2017, including the first mobile unit in North
America (Laframboise, 2017). One more site has been approved for Montreal and three sites are
set to be opened in Toronto (Lejtenyi & Gillies, 2017). There are no sites in the United States to
this date but there are many cities in the country that are working towards opening a SIF (Project
Inform, 2016).
Supervised Consumption Models
There are many different types of models for supervised consumption sites. The two
basic models are integrated and specialized. The integrated model is where a consumption area is
added to or integrated into an existing facility that provides services to drug users and the
homeless population (Hedrich, 2004). The consumption area is a separate area where clients can
safely use their drugs under supervision and is just one of many other services that are provided
by the facility. There is typically a separate registration or check-in area for staff to control
admission to the consumption area. The integrated model is the most common but there is
substantial variation in how the centers operate and in the services they provide as these are
dependent on the limitations of the facility where the SIF is co-located (Hedrich, 2004).
Specialized facilities are stand-alone sites that are exclusively for people who use drugs.
These are usually set up in places where open drug scenes are major factors in a city. Many of
these facilities offer other services above supervision of drug consumption, such as needle
exchange and drug-related medical care. They also serve as a connection to other services that
their clients may need such as drug treatment programs, healthcare, and shelters for the homeless
(Hedrich, 2004).
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Other models for SIFs include mobile units and informal sites. Mobile units are usually
large buses or vans that contain several injecting stations and have a staff member to supervise
injection. These usually drive around the city to hit high drug volume areas. Informal sites are
generally run by former and current drug users and are tolerated by law enforcement (Hedrich,
2004).
Basic services that are offered in specialized and integrated models are needle exchange
programs, basic medical care (i.e. to treat overdoses), education on safe using practices, and
referral. Staffing varies considerably depending on the site; however, all have staff available for
registration and supervision of consumption. In Europe, 60-70% of facilities offer access to a
nurse or physician (EMCDDA, 2017).
Impacts of Safe Injection Services
In 2014, a systematic review was written on the evidence of the positive and negative
consequences of safe injection services (Potier, Laprévote, Dubois-Arber, Cottencin, & Rolland,
2014). There were seventy-five relevant articles included and the authors found that SIFs were
effective in promoting safe injection practices, attracting marginalized injection drug users,
reducing frequency of overdoses, and enhancing access to health care. There were no cases of
overdose deaths within any of the facilities in which this was evaluated. In Vancouver, there was
a 35% decrease in the number of lethal overdoses around the facility (Potier et al., 2014).
Furthermore, SIFs were associated with reduced numbers of dropped syringes and public drug
injections. They did not find any increase in drug use, drug trafficking, or crime in areas
surrounding SIFs (Potier et al., 2014).
While the studies indicated that there was not an increase in local people who use drugs
around a SIF, there was not a decrease either (Potier et al., 2014). One of the limitations of the
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studies included in this review is that most of the samples for these are convenience samples so it
is difficult to determine how representative the results are for all people who use drugs.
Furthermore, many of the places that are studied have eligibility requirements which means that
there would be a subset of people who would not be able to utilize these services (Potier et al.,
2014).
Barriers and Facilitators for Safe Injection Services in San Francisco
United States. There are no legally sanctioned SIFs operating in the United States to this
date. While there are no laws that allow or forbid SIFs, there is some controversy about how drug
laws are interpreted creating some difficulty in establishing these services in the U.S. There are
laws in 19 states that authorize syringe exchange programs and/or pharmacy syringe sales and
these laws could be extended to include allowing injecting as well. However, there are issues
involving the consumption and possession of illegal drugs on the premises (Beletsky, Davis,
Anderson, & Burris, 2008).
These issues are further complicated by how police want to enforce certain laws and the
political climate. If police are not supportive and involved, there would be a risk that clients
might be arrested for drug possession when they are entering a facility. There would also be risks
for the staff members that work there, especially if they are licensed professionals. The situation
can get complicated if a state or local government authorizes a SIF but the federal law
enforcement agencies view it as a challenge to the existing national drug laws (Beletsky et al.,
2008). Furthermore, depending on the political party that has control of local, state, and federal
government, enforcement and acceptability may change dramatically.
There is also a lot of stigma associated with drug use and opponents of SIFs fear that it
will increase drug use, condone drug use, or have a negative impact on public order (Semaan et
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al., 2011). There are some people who have issues with interventions for injection drug users due
to their negative attitudes towards this population. Access to funding may also be limited based
on constrained budgets and how important an issue it is for the U.S. health care system (Semaan
et al., 2011).
San Francisco. There are many factors that might affect the success of a SIF in San
Francisco. There has been some research into the feasibility and acceptability of establishing safe
injection services in San Francisco. Recently, researchers estimated the economic costs and
benefits of establishing a SIF in San Francisco, considering potential savings from averted HIV
and HCV infections, reduced skin and soft tissue infection, averted overdose deaths, and
increased medication-assisted treatment uptake. It was found that a $2.33 savings would be
generated from each dollar spent on a SIF and would generate an annual net savings of $3.5
million for a SIF with 13 booths (Irwin, Jozaghi, Bluthenthal, & Kral, 2016).
Furthermore, there have been studies (Kral et al., 2010) done among injection drug users
(IDUs) in San Francisco regarding their willingness to use a SIF. It was found that 85% of IDUs
reported they would use a SIF, especially among those who have injected publicly (Kral et al.,
2010). However, in a qualitative study of community stakeholders in the Tenderloin where there
is a lot of public injecting, many expressed concerns that a SIF might increase illicit activities
and attract more IDUs to the neighborhood and increase the stigma associated with the
Tenderloin (Wenger, Arreola, & Kral, 2011).
In April 2017, the San Francisco Board of Supervisors passed a resolution for the
Department of Public Health to form a Task Force to develop recommendations on safe injection
services in San Francisco. They will submit a recommendation in three months from the first
meeting to the Mayor and the Board of Supervisors (“Safe injection services task force,” 2017).
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There is also a bill, AB 186, in the California Assembly to legalize injection drug use under the
supervision of health care professionals (Eggman, Wiener, & Friedman, 2017). As of July 2017,
this bill had already passed the California State Assembly and was in the California Senate. AB
186 would allow specified counties or cities to authorize the operation of supervised injection
services programs for adults that includes a hygienic space supervised by health care
professionals where PWID can consume pre-obtained drugs, sterile consumption supplies, and
access to referrals to substance use disorder treatment. This bill would exempt a person from
existing criminal sanctions solely for actions or conduct on the site of a safer drug consumption
services program authorized by the city or county (Eggman et al., 2017).
Safer Inside: A Community-Driven Initiative for a Healthier Tenderloin
Background
The Safer Inside coalition was founded in the spring of 2015. It started as a group of
people working in the Tenderloin district who came together to discuss public safety. They were
particularly concerned with the number of used needles on the street and how often public
injecting was visible. The solution that the group came to was supervised injection services and
so they became the “needle group”. This multi-sector community-driven collaboration is
comprised of leaders representing business, education, philanthropy, public health, law
enforcement, and social service non-profit organizations with the goal of improving the health of
the Tenderloin community and individual drug user health.
Coalition characteristics
The Safer Inside Coalition now consists of members from Dataway, DeMarillac
Academy, Drug Policy Alliance, Episcopal Community Services, Glide, Gubbio Project,
Hospitality House, St. Anthony Foundation, San Francisco AIDS Foundation, Urban Survivors
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Union, Saint Francis Foundation, San Francisco DA’s Office, SF Department of Public Health,
Mayor’s Office of Economic and Workforce Development, SF Tenderloin Police Department,
and people who use injection drugs. Most of the group members are volunteers who participate
in addition to their current jobs. The Tenderloin Health Improvement Partnership (TLHIP) with
the support of Saint Francis Foundation hired an outside consultant to be the group organizer and
provides incentives for people who use drugs to participate in the monthly meetings.
Objectives and Action Steps
The mission of the Safer Inside collaboration is to improve the health and safety for all
persons who live, work or congregate in the Tenderloin, and to promote a humane response to
persons who inject drugs (PWID) through a Four Pillars Approach to individual and community
harm reduction. The Four Pillars framework is widely used in substance use harm reduction
programs and focuses on prevention, harm reduction, treatment, and law enforcement. The Safer
Inside group added “recovery” and “monitoring and evaluation” to the framework. Community
members from each pillar were involved in the group. The objectives of the Safer Inside
collaboration are to:
1. Reduce the detrimental effects of substance use and addiction among persons who use
injection drugs
2. Reduce community exposure to improperly discarded needles and syringes
3. Reduce public injecting drug behavior
4. Increase the availability of syringe disposal options
5. Increase opportunities for safer injection
6. Help PWID to access services – medical, detox, and treatment
Seven priority recommendations were identified which were:
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•

Provide peer outreach to people who inject drugs in the Tenderloin

•

Develop a public information campaign

•

Develop an operational plan to establish a supervised injection site

•

Develop an operational plan to establish a clinical detoxification facility,

•

Develop an operational plan to establish a drug user resource center

•

Enforce local practices for drug-related offenses

•

Support a research plan of a two to three-year demonstration project.
Problem Analysis
It was decided, based on research from other harm reduction programs, that the best way

to achieve the objectives of the Safer Inside coalition was to open a SIF in the Tenderloin district
of San Francisco. Before organizations in the Tenderloin would feel comfortable with this, they
needed to see operational plans on how it would work and how much it would cost. Furthermore,
the coalition needed to decide whether an integrated or specialized model would be more
appropriate or feasible in the Tenderloin.
The goal of this capstone project was to develop two potential operational plans for
specialized and integrated safe injection services for the Tenderloin district in San Francisco.
These would be presented to executive directors of harm reduction programs in the Tenderloin to
determine which model they would be able to support and what additional resources they may
require to implement a SIF in the community.
Methods
Since official safe injection sites have never been operated in the United States, a
thorough literature review was done to search for information on how safe injection sites have
been operated in other countries. The review included peer-reviewed journal articles, websites,
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and news articles. Information regarding operations was compiled to create a better
understanding about the mechanics of operations with a focus on staffing, space allocation,
restrictions, eligibility requirements, and services offered.
Data were also collected from members of the Safer Inside coalition to assess what San
Francisco-specific features they wanted to include. This information was gathered based on
comments made during coalition meetings and during additional informal interviews and
discussions with key members of the coalition. Most of the information gathered at this stage
was general but notes were made from each conversation and were later analyzed to determine
whether particular desired features emerged that differed from those in use in other sites.
After collecting this information, an outline was made addressing different aspects of
how two different models of safe injection sites might be run. The draft outline was presented to
the coalition for their specific feedback. This was to obtain more detailed information from them,
as well as give them a clearer vision of how safe injection facilities might look in San Francisco.
The outline was distributed via google doc to members of the coalition and asking for their
specific notes and recommendations about the different components. This approach resulted in
feedback from only one member. Several weeks later, a conference call was set up between
members of the coalition from harm reduction organizations that are potential hosts of a SIF.
During this conference call, the points from the outline were discussed to agree on assumptions
for the basis of safe injection services in the Tenderloin. This meeting was recorded and notes
were taken to extract more questions and themes.
Feedback from the stakeholders was synthesized with information from the literature
review and then analyzed to put together a more detailed outline and a set of major assumptions
for two different models (Figure 1).
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Figure 1: Operational Plan Assumptions Outline Used in Coalition Meetings
Major Assumptions for Centralized Location
➢ Open 365 days/year
➢ Start at 16 hrs/day
➢ 15 booths (maximum)
➢ Physical space
▪ Reception/waiting room
▪ Injecting area with area for resuscitation and sinks for washing hands
▪ Chill out room
▪ Bathrooms
▪ Locked closet/storage for supplies
▪ Private spaces for counseling/private medical services etc
➢ Staffing
▪ Licensed clinical personnel (2 present at all times) – according to Insite staffing
▪ Peer health educators (7 present at all times) – according to Insite staffing
▪ Medical/program director (only available 8 hrs/day)
▪ Security officer (at all times)
▪ Social worker (only available 8 hrs/day)
➢ Services offered
▪ Provide safe injecting supplies
▪ Primary health care
▪ Safer injecting education
▪ Overdose prevention education
▪ Counseling
▪ Refreshments in chill out area
▪ Clothes
❖ Major Assumption for De-Centralized Location
➢ Open during days/hours of site
➢ 2 booths
➢ Physical space
▪ Use existing reception/check-in
▪ Have injection booths in location where there is room for privacy but can be
supervised by clinical personnel
▪ Another space where client can hang out after injecting
➢ Staffing
▪ At least 1 licensed personnel
▪ Peer health educators
▪ Other staff support from existing organization
➢ Additional service provided (on top of already existing services)
▪ Provide safe injecting supplies
▪ Primary health care (wound care, HIV and STI testing)
▪ Safer injecting education

16
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The outline was formed by utilizing the Supervised Injection Services Toolkit from
Toronto for program components that needed to be considered (Toronto Drug Strategy
Implementation Panel, 2013). Remaining, unanswered questions were noted (Appendix A).
These drafts were presented at a monthly coalition meeting to elicit more feedback. Detailed
notes were taken to extract more themes. Another meeting was scheduled with more key
stakeholders, such as users and representatives from organizations to discuss and answer the
remaining questions. Operations-related themes were taken from the Yes to SCS city-wide
coalition meetings and the San Francisco Department of Public Health and Board of Supervisors
Safe Injection Task Force meetings.
The data for the budget was collected by contacting suppliers for needle exchange
programs in San Francisco to estimate the costs of supplies. Data from government websites
were used to collect information on average wages for staff. This information was collected and
inputted into Excel based on the assumptions that were agreed upon in the operational plan.
Findings
Based on the literature review and the discussions with the Safer Inside coalition
members, the plan was based on a number of underlying assumptions:
•

Safe injection services are necessary for the health and safety of the community and drug
users

•

The target population are PWID who are homeless and/or primarily use drugs in public
areas in the Tenderloin

•

A SIF would be beneficial in the Tenderloin

•

A SIF would be able to get funding and support
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Success of the SIF would rely on utilizing good neighbor strategies by working with local
law enforcement, businesses, and community members

•

The SIF would start as a 2-year demonstration project that would lead to more SIFs by
year 3

•

Evaluations will be done to assess success by collecting data on who is using the service,
how many referrals are being made, and health and neighborhood impacts (See Appendix
B for more details)

Overview for centralized model
The centralized model is an example of a site that is an independent program (potentially
supported by existing organizations) in the Tenderloin and would offer a safe, clean space for
PWID to use under supervision.
Service model for clients:
1. Clients arrive at the reception area and check-in. On the first visit, demographic, risk
behavior, injecting practices, and other healthcare and living situation measures (see
Appendix B for types of questions) would be obtained for monitoring and evaluation
purposes and the client would be given a unique identifier that they would use for entry at
each future visit. Clients would also be asked about types of drugs being brought in at
each visit and assessed for special needs/accommodations
2. Clients would wait in reception until an injection booth is available and then they would
proceed to the injecting area.
3. At the injection area, clients would wash their hands and be given clean supplies and
proceed to an injection booth where they would be given approximately 30 minutes to
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inject (may take longer if necessary). Clients would be supervised by the staff and have
the option of receiving education about safe injecting if needed.
4. After successful injection, they would proceed to the user lounge where they can relax, be
monitored by staff to ensure safety (e.g. prevent overdose) and talk to their peers and
staff. Here, other referrals can be made if the client is interested.
5. Clients can spend approximately an hour in the lounge and this can vary based on need
and space requirements.
Overview for de-centralized model
The de-centralized (or integrated) model is an example of what would be added to an
existing harm reduction program in the Tenderloin to provide a safe, clean space for PWID to use
under supervision.
In this setting, the service will look different depending on the program that it is
integrated with; however, this is the basic model of how it will work for clients in this type of
setting:
1. Clients would check-in at a private area where demographic, risk behavior, injecting
practices, and other healthcare and living situation measures (see Appendix B for types of
questions) for monitoring and evaluation purposes would be collected and a unique
identifier would be assigned. Clients would be asked about types of drugs being brought
in each visit.
2. While clients are waiting to use the injection booths, they could use the waiting rooms or
space that already exists in the facility.
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3. Clients would then go into the injecting area, wash their hands, and collect clean injecting
supplies and inject their drugs at a booth under supervision. Other safe injecting
education will be provided if needed.
4. After successful injection, clients can spend time in the existing space of the facility for
continued monitoring and clients can access the other services that the existing
organization offers.
Justifications for Program Features
The two operational plan outlines were divided into sections outlining the features that
each model would include (see Appendix C for more details of what is included).
Services offered. The proposed services are based on the literature of what other SIFs
offer (EMCDDA, 2017; Hunt, 2006; Schaffer, Stover, & Weichert, 2014; Schatz & Nougier,
2012) and based on conversations with the members of Safer Inside as to the key services they
wanted to offer to the community. The services are also within the minimum requirements for
safe consumption services outlined in AB 186 (Eggman et al., 2017). Within the integrated
model, more services may be offered depending on what the facility already has to offer.
Furthermore, if the SIF were to be integrated into a syringe-exchange program, the clean
injecting equipment will already be available.
Hours of operation. The hours suggested in the centralized site are a starting point;
hours can be expanded or decreased as the budget allows. However, the starting point of two 8hour shifts allows for increased availability of the service, as evidence suggests that users would
prefer a space to be open 24 hours a day, according to the San Francisco Board of Supervisors
Task Force Meeting on July 21, 2017. Furthermore, the hours of 6am-2pm and 4pm-midnight
were suggested by members of the coalition to provide services for those who need to use early
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in the day and later in the evening. This also will help to bring public injecting indoors during
morning and evening commute times. The hours for the de-centralized model can also be
adjusted as needed based on the characteristics of the specific site.
Physical design. The design for the centralized model is based on Insite in Vancouver
and the medically supervised injection site in Sydney (the two models with the most research).
The addition of curtains around a larger booth was suggested by members of the coalition to
provide additional privacy for those who need to inject into more sensitive areas of the body and
can be used for private medical care. The need for mirrors and sinks in the injecting areas are for
better ability to monitor clients and promote clean practices. The user lounge is based on Insite as
a comfortable area for clients to hang out after injection under supervision if needed. This would
also be an area where they can talk to staff about referral to other services.
For the de-centralized model, the recommendation is to have a private area for check-in is
to keep this service separate from the other services that are offered at the facility and for
evaluation purposes. It is also to protect the privacy of the clients who are there to use this
service. The model for this could vary depending on the space restrictions of the existing
program. The proposal of the use of the existing waiting room for monitoring of clients after
using is to continue to make sure that clients are safe before sending them back out on to the
streets.
Staffing. The staffing was decided by coalition members based on presumed need. The
reason that a licensed clinical staff is to be available at all times in both models is for
demonstration purposes. It is the model that is used at many of the researched sites (EMCDDA,
2017; Schaffer et al., 2014) and is required by AB 186 (Eggman et al., 2017). This is by no
means the only model, and sites can be opened that do not have licensed clinical staff but this is
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the proposition to increase safety and for compliance under AB 186. Peer health educators are
used at Insite, and are supported by the coalition as they can assist in talking to clients and
getting them comfortable and providing education and supervision. Peer health educators could
also assist in cleaning up after each injection. In de-centralized sites, potentially two or more
peer educators may need to be in place to have at least two people able to respond to a medical
emergency and still have staff that can continue to monitor the other clients. If the existing
program already has staff that can help monitor, it may not be necessary to add more staff. Safety
monitors are essential for security of the site and help to de-escalate situations and AB 186
mentions having adequate security in place.
Supplies. Recommendation on supplies were based on input from syringe exchange
programs and members of the coalition and on supplies that are listed at other sites.
Service rules. Service rules were based originally on rules that are in place in other
existing sites in other countries. However, due to some research on the consequences of having
too many restrictions to access (Schaffer et al., 2014), the suggested rules were agreed upon by
members of the coalition to make the site low-barrier. While there is a rule for clients to be over
18 per AB 186, IDs will not be checked. The rules that were suggested reflect the goals of the
coalition to serve the majority of PWID in the Tenderloin.
Budget. The budget (see Appendix D) was set up with all the categories that need to be
included for a specialized site based on the operational plan outline. It includes salaries for staff
for a site that is open 16 hours per day with up to 15 booths. The numbers can be adjusted as
needed depending on the model that is chosen and actual cost of services or items. There are still
many gaps where the costs are unknown but can be determined by the organizations that are
considering the development of a SIF.

SAFE INJECTION FACILITIES

23
Discussion and Implications

The operational plans were developed based on the literature review and feedback from
community members. The two operational models presented gave an overview of how the
program would work in each setting and what features would need to be included. The report
presented to the group contains a basic introduction to the Safer Inside Coalition, the major
assumptions the plan was based on, information about AB 186, an overview of service for both
models, the outline of included features for both models, the justification of features, operational
evaluation components, and other considerations that still have not been decided on. A
preliminary budget was also added; however, it is not complete and there are pieces that still
need to be determined. The plans are still an ongoing discussion as there are many factors that
need to be considered and many different opinions on the model and features.
Supporting and Opposing Forces
There are several factors that positively impact a specialized model. There is a lot of
support within the harm reduction community for these services to be offered. It could be run by
a memorandum of understanding with existing harm reduction programs so several programs
could contribute to the site (either through funding, personnel, supplies, etc). A specialized model
would also be easier to evaluate as it will focus just on the safe injection services and could serve
a larger number of clients. However, some of the negative aspects of a specialized model are that
it might not be able to provide many additional services and clients would then need to go to a
different location for other services. It would also be more expensive due to rental costs of a
building and starting a program from scratch.
The integrated model is the most popular model around the world (Hunt, 2006; Schaffer
et al., 2014; EMCDDA, 2017). There are several harm reduction programs in the Tenderloin that
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have already expressed interest in adding this service on to their program. It would allow PWID
access to other services without having to go to a different location. It may be less expensive as
many of the programs could use existing space, staff, and supplies. However, it may be difficult
for other clients who are on opioid substitution therapy or going through detox to know that
drugs are being used in the same facility and may lead to relapse. It would also put more
responsibility and liability on the existing program and it would be harder to see an impact if
there are a limited number of people who can be using the service.
The performance measures in Appendix B are an important part to ensuring that the SIF
is successful and will continue to be supported. The evaluation plan is another piece of
operations that needs to be expanded upon in further discussion. There will be data collected on
every aspect of the program. For example, there would be a record of demographic, risk
behavior, injecting practices, and other healthcare and living situation measures for clients; how
often clients utilize the service; how many supplies are given out; what types of and how often
safe injecting education is given; what types of and how often medical treatments are given; how
many overdoses/reversals; and what types and how often are referrals to other services.
Limitations of Methods
There were several challenges that arose from the type of data collection utilized for this
project. First, most of the data was collected from secondary sources because it could not be
collected from primary sources due to the lack of SIS services in the United States. This made it
difficult to find specific information on how SIS are run as the data were limited to whatever
information was published. It also proved difficult to get responses from people in other
countries that currently have these services.
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Furthermore, it was difficult to plan for scenarios without specifics on where the SIS
might be located (if it is a specialized model) or what organizations would house it (if it is an
integrated model). For example, some organizations have connections with licensed healthcare
professionals while others do not, so individual agency characteristics could limit the type of
services that could be offered in a specific location. This information was important for an
accurate outline for the operational plans. However, at the time of the study, this information was
still not decided.
Other challenges arose from working with a large group of people who were all very busy
and had separate full-time jobs. It was difficult to get all these key people to weigh in and
provide information that would be useful to the development of the project. This was further
complicated by the fact that this coalition was also focusing on outreach to support this idea so
there was a split in focus. Due to these challenges, the best way to get feedback from the
members was to provide a hard copy of the drafts in a meeting that they had agreed to attend.
Finally, if this project were repeated with more resources and time, it would be helpful to
visit at least one of the already existing SIFs and get an existing operational plan that could serve
as a model. It would also be helpful to conduct some primary data collection from stakeholders
and users about components that are important to them in a SIF. However, this data has already
been collected via a study conducted in 2010 and another recent survey in the fall of 2016 and
beginning of 2017. Unfortunately, the results from the recent studies are restricted since the
studies have not been published.
Other Limitations
Due to time constraints and the difficulty in getting feedback from different key players,
this operations outline is just the beginning. The proposal will undoubtedly be revised and added
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to many times before a service model is agreed upon and implemented. There are many more
stakeholders that should have a say in some of the program design and services that were not
able to give their input due to the limited time in which this project was conducted. There are
also the Yes to SCS coalition and the Department of Public Health’s task force working on this
topic, so their input may have an impact on the final operational plan that gets approved.
Furthermore, while the intent of the Safer Inside coalition is to open a SIF in the
Tenderloin regardless of the bill that is in the California Legislature, if AB 186 does not pass it
will raise more questions and concerns that would need to be addressed to protect the clients and
staff of the facility. The federal government also does not have any exemptions to laws that
would allow for SIFs and so there is always the added threat of the federal government
interfering with operations.
Recommendations for Next Steps
Moving forward, these plans should be built upon, adding more input from community
members and PWID. There should also be people with legal expertise working with programs
that are interested in being involved to address liability and licensing issues. Input and
cooperation with the police is necessary to ensure that everyone agrees in terms of what is
acceptable and what is not. The important part of a SIF, regardless of model, is for it to be a safe
place for PWID, so policies need to be put in place to ensure safety. It would be helpful if people
from other existing SIFs around the world could come to San Francisco and help to inform what
works and what does not to make sure that the program that is designed will function well and
reach the largest number of people. Continuing to educate the public and officials about the
scientific benefits of SIFs is crucial to making it successful.
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Appendix A: Questions Requiring Input from Coalition Members
➢ How long will clients need to be in the facility?
➢ What hours do we want for the centralized location?
▪ 8 am – midnight
▪ 6 am- 2pm, 4pm – midnight
▪ Other?
➢ What level of clinical personnel is needed?
▪ Do we need them to provide prescriptions? (NP)
▪ Assessments and treatment (Nurses)
➢ Scope of practice for peer health educators
▪ They can be trained in naloxone administration and CPR and assist with
resuscitations or just focus on education
➢ Scope of practice for social worker/counselors?
➢ What other medical services are we offering besides emergency procedures, resuscitation,
wound care, and HIV/STI testing)
➢ What type of counseling are we going to offer?
▪ Referral to services?
▪ Therapy?
➢ Service rules (other assumptions we need to agree on):
▪ Restrictions on types of drugs allowed to inject
• If so, which ones? What treatments do we need?
▪ Restrictions on drug dealing on site
▪ Restrictions on sharing drugs
▪ Restrictions on body sites where people can inject
▪ Assisted injection
▪ Time limits for injecting or using chill out room
▪ Verbal or physical violence
▪ Limit of number of injections per visit
▪ Expulsion for breaking rules (i.e. what would the length of expulsion be)
▪ Dispute resolution process
➢ Are we going to offer to test drugs?
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Appendix B: Performance Measures
•

•

•

How much?
o # SIFs
o - Service utilization patterns
o # of people
o Frequency of use
o Number of new and existing clients of the broader health service
o Services accessed on site
o Reasons for using service
o # tests for HIV and other blood borne illnesses
o # overdose events treated successfully
o Service referral patterns (# and type of referrals)
How well?
o % who are referred to recovery services
o % who recover
o % of total TL IDUs who use services
o % repeat clients
o % satisfied with service
o % awareness of SIS in TL
Is anyone better off?
o Degree of successful referral
o % understand importance of referral
o % motivated to attend referral
o % attended one visit
o % attended repeat visits
o % reporting help-seeking behavior
o % exhibiting basic health and hygiene
o % of peers responding effectively to overdose offsite
• Health impacts:
o o Incidence of HIV, ep C, hep B infections
o o Incidence of abscesses and other skin/vein related problems
o #% fewer overdose deaths or overdoses
o #/% of successful recoveries

*Important to note that impacts will be seen/measured in a several block radius of the site as that
is the expected area to have the greatest impact
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Appendix C: Program Details Outline for Both Models
Outline for Centralized Model
Services offered:
•

•

•

•

•

•

Provide safe injecting supplies – such
as syringes, alcohol, cookers, sterile
water, tourniquets, etc. and safe
smoking supplies
Referral to primary health care –
connecting clients to health care
providers so that they are in the health
care system and are not relying on
expensive emergency department
visits
Treat immediate health concerns
directly related to injecting – this
includes treating overdoses, wound
care for injection related wounds,
administration of oxygen and other
medications related to adverse
reactions of drug use, and calling
paramedics if further emergency
medical attention is required
Harm reduction education
o Safer injecting education, such
as vein care, sterile practices,
nutrition, dosing, appropriate
disposal of equipment, HIV
and HCV prevention
education, etc.
o Overdose prevention education
o Support for long-term users
Harm reduction counseling
o This would include linkages to
treatment, detox, other
counseling services, opioid
replacement therapies
Testing for fentanyl on request with
fentanyl testing strips

Hours of operation:
•
•

Open 365 days/year
Start at 16 hours/day (two 8-hour
shifts)

Outline for De-centralized Model
Services offered (in addition to services
already provided):
• Provide safe injecting supplies – such
as syringes, alcohol, cookers, sterile
water, tourniquets, etc.
•

Treat immediate health concerns
directly related to injecting – this
includes treating overdoses, wound
care for injection related wounds,
administration of oxygen and other
medications related to adverse
reactions of drug use, and calling
paramedics if further emergency
medical attention is required

•

Harm reduction education
o Safer injecting education, such
as vein care, sterile practices,
nutrition, dosing, appropriate
disposal of equipment, HIV
and HCV prevention
education, etc.
o Overdose prevention education
o Support for long-term users

•

Testing for fentanyl on request with
fentanyl testing strips

Hours of operation:
•

Open during days/hours of the
existing program
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•

May expand hours or offer this service
at different hours depending on the
site
Physical design:
Physical design:
Reception/waiting room
Private area for check-in
• space where clients can check-in and
• There could be different models
wait for booth to become available.
depending on the agency to promote
This room would contain seating and
privacy (For example, could be a
water filtration system and cups so
small desk off to the side, an
clients have access to water while they
administrator collecting information
wait.
with a laptop or tablet)
•

•

Proposed hours: 6am-2pm, 4pm midnight
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Injecting area
contain up to 15 booths or injecting
stations, each booth would consist of a
table (that is easily sanitized), chair,
and mirrors. There would be a nurses’
station for supplies, at least one sink
for washing hands, and a disposal area
for used equipment. Mirrors placed on
either end of the room to make it
easier for monitoring clients. There
could be a booth at the end or corner
of the room with curtains that come
around for more privacy (if needed).
User lounge
safe space with seating for clients to
utilize after injecting to continue to be
monitored and talk with staff and
peers
Bathrooms

•

Injecting area
contains minimum of 2 booths or
injecting stations, each booth would
consist of a table (that is easily
sanitized), chair, and mirrors. There
would be at least one sink for washing
hands and a disposal area for used
equipment. There would also be a
supervision area or table containing
supplies and emergency equipment
and crash cart. Must be enough space
for supervision of injections

Clients could use existing waiting
room for waiting before and after injection

Private space that can be used to store
supplies and provide private medical services
or counseling
Staffing:
Staff:
Licensed clinical personnel (minimum
RN, 1 per shift)
• their role would be for treatment such
as medical emergency, wound care,
and referral to other medical services

Staffing:
Staff:
Licensed clinical personnel (minimum
RN)
• one nurse for supervision and for
treatment such as medical
emergencies and wound care.

Peer health educators (minimum 4 per

Peer health educators (minimum 1 per

shift)

shift)

SAFE INJECTION FACILITIES
•

•

there would be one in reception, at
least 2 in injecting area for
observation and can assist with
administering naloxone and other
safer injecting education, and one in
user lounge for supervision and
referral to services
Administrator (1 per shift)
work in reception and check-in all
clients and collect data

Program manager (can work 40
hrs/wk, but be available on-call)
• this would be the manager of the
facility
•

•

•

•
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•

•

for monitoring clients after injection
and can also provide some harm
reduction education

Administrator (1 per shift)
work in reception and check-in all
clients and collect data

Depending on existing program staff,
may need additional staff because two people
must be available at all times to respond to
medical emergencies

Medical director (sub-contracted)
available for managing more complex
medical issues
Safety monitor (at least 1 per shift)
helps provide a safe environment for
staff, clients, volunteers, and other
occupants of the SIF by means of
crisis intervention and conflict deescalation
Navigator (1 per shift)
Navigators work with clients who are
not in care to identify factors
contributing to a lack of engagement,
such as a loss of health benefits,
substance use, mental illness and
homelessness. Navigators work to
address these barriers by providing
referrals to social services, and assist
with re-linking clients to care
Program associate (40 hrs/wk)
in charge of scheduling, logistics,
payroll

Maintenance/cleaning (sub-contracted
or potential peer-contract)
•
•

Key qualifications
Non-judgmental
Experience working with PWID

•
•

Key qualifications
Non-judgmental
Experience working with PWID
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•

Understanding of harm reduction
principles
• Understanding of overdoses,
HIV/HCV infections, substance use
treatment modalities, homelessness,
stigma, etc
Training:
• CPR
• Universal precautions –
prevent/respond to needle-stick
injuries
• Wound care/assessment
• Stimulant overdose training
• Naloxone training – DOPE
• Safe handling of biohazards such as
injecting supplies
• De-escalation training
• Crisis training
• Cross-culture training
Supplies:

Understanding of harm reduction
principles
• Understanding of overdoses,
HIV/HCV infections, substance use
treatment modalities, homelessness,
stigma, etc
Training:
• CPR
• Universal precautions –
prevent/respond to needle-stick
injuries
• Wound care assessment
• Stimulant overdose training
• Naloxone training - DOPE
• Safe handling of biohazards such as
injecting supplies
• De-escalation training
• Crisis training
• Cross-culture training
Supplies:

Wound care supplies – gauze,
bandages, saline, tape, lidocaine, long q-tips,
antibiotic ointment, towels
Naloxone
Oxygen tanks, masks, tubing
Sharps container
Safe injecting supplies – syringes,
tourniquets, alcohol swabs, sterile
water/saline, cookers, pill filters, lighters
Clean smoking supplies – rubber stem
tips, alcohol swabs, copper chore boy, sugarfree gum
Universal precautions – gloves,
masks, eye wear, soap for handwashing, hand
sanitizer, paper towels
Cleaning agents
Fentanyl testing strips

Wound care supplies – gauze,
bandages, saline, tape, lidocaine, long q-tips,
antibiotic ointment, towels
Naloxone
Oxygen tanks, masks, tubing
Sharps container
Safe injecting supplies – syringes,
tourniquets, alcohol swabs, sterile
water/saline, cookers, pill filters, lighters

Service Rules:

Service Rules:

Universal precautions – gloves,
masks, eye wear, soap for handwashing, hand
sanitizer, paper towels
Cleaning agents
Fentanyl testing strips

At least 18 years of age

At least 18 years of age

Only injectable drugs

Only injectable drugs

All drugs must be procured prior to
entering the site

All drugs must be procured prior to
entering the site
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No sharing of drugs brought into site

No sharing of drugs brought into site

Staff will not assist injection

Staff will not assist injection

Estimate 30 min per injection,
estimated hour in lounge based on need and
space requirements
Protocols will be in place for the
safety and well-being of all people (such as
those from existing behavioral protocols from
harm reduction agencies)
No limit on times clients can use the
site, however, they need to get back in line
after use

Estimate 30 min per injection,
estimated hour in lounge based on need and
space requirements
Protocols will be in place for the
safety and well-being of all people (such as
those from existing behavioral protocols from
harm reduction agencies)
No limit on times clients can use the
site, however, they need to get back in line
after use
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Appendix D: Preliminary Budget
Budget for Centralized Site
Assumptions:
30 min per injection: 2 injections per hour per booth
60 min in user lounge
Check in:
15 min for first time
5 min for return visit

This budget is based on centralized site, open 16 hours/day, up to 15 booths - potentially 480
injections per day
Salaries
FT Hourly
Salary
Benefits
total per
total
E
at 35%
FTE
RN
2
$60
$124,80
$43,680 $168,48
$336,96
0
0
0
Peer Health Eds
8
$17.50
$36,400
$12,740 $49,140
$393,12
0
Administrator
2
$20
$41,600
$14,560 $56,160
$112,32
0
Program Manager
1
$35
$72,800
$25,480 $98,280
$98,280
Safety Monitor

4

$18

$37,440

$13,104

$50,544

Navigator

2

$24

$49,920

$17,472

$67,392

Program Associate

1

$22

$45,760

$16,016

$61,776

Relief Staff

2

$22

$45,760

$16,016

$61,776
Total:

Staff Development

CPR plus First Aid
Universal precautions
Naloxone training

$1,100
0
$770

Crisis training

$500

Cross-culture training

$500

Program Expenses/Start up

$123,55
2
$1,462,9
68

Total cost for all staff - to be done at start of program,
may need to be repeated on annual, bi-annual basis
depending on staff turn-around
$2,200

De-escalation training

Harm Reduction training

$202,17
6
$134,78
4
$61,776

0

SAFE INJECTION FACILITIES
Equipment and Supplies

Sterile tables

40
Qu
ant
ity
15

Total Cost for quantity listed

$2,000

Mirrors

15

$400

Chairs

60

$3,000

Reception desk

1

$1,500

Staff counter with storage

1

$3,000

Observation mirrors

2

$200

Dividers

15

Curtains

2

SInk
Water dispenser
Lighting
Metro shelving
Crash cart for nursing station

1
3

$300

1

$500

3
3
4
12

$250
$800
$1,000

5

$5,000

5
12
2

$400

Staff desks
Folding tables
Walkie talkie/radios
Lockers for staff
Office Supplies
Computers (1 for each room, for data
collection, and 1 for program
manager and 1 for program
associate)
Phones
Internet connection
Printer
Office Expenses
Paper
Pens
Printer cartridges
Clipboards
General
Paper cups
Custodial Supplies
Mops
Brooms
Cleaning agents
Biohazard kits
Blood-cleanup kits
Sanitizing wipes

for empty cart, not including
supplies

SAFE INJECTION FACILITIES
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Soap
Paper towels
Operating supplies
Medical:
Wound care supplies
Naloxone

$0 via DOPE
project

Oxygen/oxygen tubing/masks
Universal precautions
Fentanyl testing strips
Injectng supplies:
Syringes
Cotton
Tourniquets
Alcohol swabs
Sterile water/saline
Cookers
Pill filters
Lighters
Sharps containers

Program Expenses
Software and supplies

$132/case of
500
$17/case of
600
$130/case of
800
$33/case of
4,000
$125/case of
1,000
$230/case of
1,000
$16/case of
100
$176/case of
100

tec
k
so
up

Recruitment
Utilities
Internet/Phone
Rent
Insurance
Graphic design
Branding
T-shirts/scrubs
Promotional materials
Information and referral materials
Professional Services (All these are sub-contracted, not regular staff):
MD - not full-time staff, just available for complex medical issues and/or
prescriptions

SAFE INJECTION FACILITIES
Maintenance
Biohazard pickup
Custodial
Legal
Security
(if contracted out)

42

$2
5/h
r

